Qkine Product Launch Class of 2024
Class of 2024: celebrating the products launched in 2024 including expanding our hematopoietic range and adding tuna, salmon and eel FGF-2!
17
12, 2024
12
09, 2024
Qkine collaboration with the Bertero Lab, Heart Engineering and Developmental Genomics et al. (HEDGe), University of Turin, Italy
This recent publication in collaboration with Qkine focusses on the optimization of home-brew media for the maintenance of human induced pluripotent stem cells (hiPSCs), using Qkine growth factors to allow cost-effective, practical, and reproducible culture of hiPSCs. Qkine thermostable tag-free FGF2-G3 proteins were found to be highly bioactive, necessitating an 8-fold reduction in concentration for the short (145 aa) form of FGF2-G3 in the optimized media.
30
08, 2024
The transformative power of hematopoietic stem cells in medicine
Hematopoietic stem cells (HSCs) are at the forefront of a transformative shift in modern medicine, beginning to revolutionize patient care by offering novel therapeutic treatments for a wide range of diseases. This review blog summarizes advances in the clinical use of HSCs in HSC transplantation.
16
08, 2024
Qkine is pleased to announce that it has been recertified with the international standard ISO 9001:2015 by globally respected UKAS-accredited BSI
Qkine is pleased to announce that it has successfully been recertified with the international standard ISO 9001:2015 by the globally respected UKAS accredited BSI, giving enhanced confidence in the assessment of best practices. This standard shows our dedication to raising the standard of bioactive proteins through implementation of continual improvement, scientific innovation and exceptional scientific and customer support
19
09, 2023
Qkine collaborates with the Cambridge Stem Cell Institute to facilitate same-day access to key research products for researchers at the Cambridge Biomedical Campus GalleryQkine collaborates with the Cambridge Stem Cell Institute to facilitate same-day access to key research products for researchers at the Cambridge Biomedical Campus
Qkine collaborates with the Cambridge Stem Cell Institute to facilitate same-day access to key research products for researchers at the Cambridge Biomedical Campus
Qkine collaborates with the Cambridge Stem Cell Institute to facilitate same-day access to key research products for researchers at the Cambridge Biomedical Campus
10
09, 2021
Qkine earns ISO 9001:2015 certification for protein R&D and manufacture facilities in Cambridge, UK
Qkine certified ISO9001: 2015 for its quality management system encompassing R&D, manufacturing, and operations in Cambridge, UK. Qkine supplies growth factors and cytokines to the fast-moving stem cell, organoid and emerging cultured meat sectors. Exceptional product quality and scientific support are crucial to customer's business processes and experimental outcomes.
1
08, 2017
Cambridge Enterprise and Qkine Ltd sign deal to drive stem cell and regenerative medicine research
Cambridge Enterprise and specialist growth factor manufacturer Qkine Ltd sign key licensing deal for Activin A production technology
